National Health (August 2021 First New Brand statutory price reduction) (Exercise of Ministerial discretion) Determination 2021

I, Nikolai Tsyganov, Acting Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health and Aged Care make this determination under subsections 99ACB(6A) and 99ACF(3AA) of the National Health Act 1953.

Dated       30 July 2021

1 Name of Determination

  This instrument is the National Health (August 2021 First New Brand statutory price reduction) (Exercise of Ministerial discretion) Determination 2021.  

2 Commencement

  This instrument commences on 1 August 2021.

3 Definition

In this instrument:

 Act means the National Health Act 1953.

4 Authority

This instrument is made under subsection 99ACB(6A) and subsection 99ACF(3AA) of the Act.

5 Brands of pharmaceutical items with approved ex-manufacturer price not reduced

  (1) I determine under subsection 99ACB(6A) of the Act that, for the purposes of subsection 99ACB(5), the approved ex-manufacturer price that comes into force on 1 August 2021 of the brand of pharmaceutical item specified in column 2 of item 1 in the table in Schedule 1 is to be worked out using a reduction of zero %.

(2) I determine under subsection 99ACF(3AA) of the Act that, for the purposes of subsection 99ACF(2AB), the approved ex-manufacturer price that comes into force on 1 August 2021 of the brand of pharmaceutical item specified in column 2 of  item 2 in the table in Schedule 1 is to be worked out using a reduction of zero %.

Schedule 1— Brands of pharmaceutical items with approved ex-manufacturer price not reduced